Immunotherapy in NSCLC Patients With Brain and Leptomeningeal Metastases.

Saved in:
Bibliographic Details
Title: Immunotherapy in NSCLC Patients With Brain and Leptomeningeal Metastases.
Authors: Pierret T; Thoracic Oncology Unit, Grenoble University Hospital, La Tronche, France., Giaj-Levra N; Department of Advanced Radiation Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Italy., Toffart AC; Thoracic Oncology Unit, Grenoble University Hospital, La Tronche, France., Alongi F; Department of Advanced Radiation Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Italy.; University of Brescia, Brescia, Italy., Moro-Sibilot D; Thoracic Oncology Unit, Grenoble University Hospital, La Tronche, France., Gobbini E; Thoracic Oncology Unit, Grenoble University Hospital, La Tronche, France.; Cancer Research Center Lyon, Center Léon Bérard, Lyon, France.
Source: Frontiers in oncology [Front Oncol] 2022 Apr 12; Vol. 12, pp. 787080. Date of Electronic Publication: 2022 Apr 12 (Print Publication: 2022).
Publication Type: Journal Article; Review
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2234-943X
DOI:10.3389/fonc.2022.787080